Showing results (71-80 of 5,040) with videos related to

Sort By:
Pageof 504
Multiple Sclerosis and Related Disorders|February 15, 2022
A systematic review of the effects of cannabis on cognition in people with multiple sclerosisJeffrey Landrigan, Kitti Bessenyei, Damian Leitner, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Pediatric-onset multiple sclerosis in Poland: A registry-based retrospective cohort studyWaldemar Brola, Barbara Steinborn, Maciej Niewada, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infectionDoriana Landi, Gaia Cola, Vittorio Mantero, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Understanding the role of the blood brain barrier and peripheral inflammation on behavior and pathology on ongoing confined cortical lesionsBerenice Anabel Silva, María Isabel Farías, Esteban Alberto Miglietta, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Acute optic neuritis: What do complementary tests add to diagnosis?Victoria Carla Fernandez, Andres Maria Villa
Multiple Sclerosis and Related Disorders|February 15, 2022
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysisIrene Schiavetti, Marta Ponzano, Alessio Signori, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Nicolau syndrome caused by GlatiramerSandro Ciprian, Sebastiano A G Lava, Gregorio P Milani, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAINScott D Newsome, Thomas F Scott, Douglas L Arnold, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
A web-based life-style, exercise and activity intervention for people with progressive multiple sclerosis: Results of a single-arm feasibility studyMonica Busse, Rebecca Playle, Julie Latchem-Hastings, et al.
Multiple Sclerosis and Related Disorders|June 15, 2019
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre studyErica Curti, Elena Tsantes, Eleonora Baldi, et al.
Pageof 504